Organization
Bavarian Cancer Research Center
1 abstract
Abstract
Response to targeted and immune therapy in patients with NSCLC and BRAF non-V600E mutations: A retrospective, multicenter analysis within the national Network Genomic Medicine Lung Cancer (nNGM) in Germany.Org: DKFZ-Hector Cancer Institute, Network Genomic Medicine, TU Dresden, Justus-Liebig-University, University Hospital Frankfurt,